A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer

BACKGROUND: Accurate evaluation of the response to neoadjuvant chemotherapy (NAC) provides important information about systemic therapies for breast cancer, which implies pharmacological response, prognosis, and guide further therapy. Gene profiles overcome the shortcomings of the relatively limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jin, Tian, Yuan, Liu, Wei, Zheng, Hong, Xi, Yuanyin, Yan, Yuzhao, Hu, Ying, Liao, Bin, Wang, Minghao, Tang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629837/
https://www.ncbi.nlm.nih.gov/pubmed/36341435
http://dx.doi.org/10.3389/fimmu.2022.1035667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629837/
https://www.ncbi.nlm.nih.gov/pubmed/36341435
http://dx.doi.org/10.3389/fimmu.2022.1035667

Ejemplares similares